Filing Details
- Accession Number:
- 0001209191-15-063994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-05 16:02:52
- Reporting Period:
- 2015-08-03
- Filing Date:
- 2015-08-05
- Accepted Time:
- 2015-08-05 16:02:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601797 | Eric Sullivan | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-03 | 250 | $20.70 | 3,468 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-08-03 | 166 | $24.47 | 3,634 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-03 | 51 | $164.09 | 3,583 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-03 | 244 | $165.23 | 3,339 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-03 | 90 | $166.05 | 3,249 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-03 | 31 | $166.89 | 3,218 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2015-08-03 | 250 | $0.00 | 250 | $20.70 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-08-03 | 166 | $0.00 | 166 | $24.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,750 | 2023-12-02 | No | 4 | M | Direct | |
| 4,838 | 2024-03-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2015.
- The range in prices for the transaction reported on this line was $163.67 to $164.44. The average weighted price was $164.0888. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $164.72 to $165.71. The average weighted price was $165.2264. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $165.73 to $166.66. The average weighted price was $166.0459. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $166.81 to $167.06. The average weighted price was $166.8916. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes 128 shares acquired under the bluebird bio employee stock purchase plan on July 31, 2015.
- This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
